Agree...........but we should also all be able to agree that they will be asked about the status of a partnership, the timing of a partnership, perhaps even if they are going on now, etc., etc.
I don't think the company will provide many details other than to say they are pursing a partnership.........but they will be asked.
We should all be able to agree upon that.
What I would really like to know is who/how the partnership details will be decided upon. How much say/sway does Sands have now that Invus is the majority partner.
The original date for
the earnings was
scheduled for 8/6.
Now it was moved to
7/31 as a conference
call, where there can
be a Q & A.
Others on the board
who've been with LXRX
can further enhance
others when there was
an earnings, was it
just a blurb...
Not being analytical
but the signs of major institutional
interest and the conference call being
moved up seems to give
credence to their
To start a partnership, a seller like LXRX needs a buyer who's willing to pay a fair price. None of us are privvy to BD conversations, but it's fair to say that LXRX is probably asking a lot for 4211. That's fine however it requires a buyer to believe the information and to really need the asset. The big players in T2D (Merck, Lilly, NovoNordisk) don't appear to be interested. Perhaps they're cautious about the value of an SGLT2 inhibitor based on existing data and don't want to underwrite the cost of phase III for a diabetes drug that will at best be the third or fourth on the market. Buyers also have to have confidence in the seller and word on the street is that LXRX is tough to deal with because they think they're way is the best, their compounds are the best and that justifies a high price.
Coming soon. As the compounds keep progressing the terms of the deal improve for LXRX, as long as they can keep producing promising results. Phase 3 will be partnered, just make sure you load up before the news breaks.
All true, but you don't have to wait for an actual partnership for this to go up. All it takes for this to rocket up is for shorts to get nervous, as they must be about the imminent conference call. And they SHOULD be nervous ... I wouldn't want to be short with unlimited loss potential.
I have one, Sands put out too many what I think are misleading PRs and he continued to rob the shareholder till yearly. bonuses that he never deserved for instance...secretary getting elaborate bonuses...come on...LXRX has been his very own private little piggy bank at our expense and this was transparent to all who would partner with them. In my opinion only. All Sands fault.